Zobrazeno 1 - 10
of 28
pro vyhledávání: '"N. Vyalova"'
Autor:
Ekaterina V Mikhalitskaya, G. G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova, N. Vyalova, O. V. Roshchina, O. Yu. Fedorenko
Publikováno v:
Nevrologiâ, Nejropsihiatriâ, Psihosomatika, Vol 13, Iss 3, Pp 48-52 (2021)
Alcohol dependence (AD) and affective disorders (ADs) are serious medical and socio-economic problems of modern society. It is hypothesized that both disorders share a common neurobiological basis. Phosphatidylinositol-4-phosphate-5-kinase type 2 alp
Autor:
Anastasia Levchenko, N. Vyalova, G. G. Simutkin, Nikolay A. Bokhan, Timur Nurgaliev, Svetlana A. Ivanova, Ivan V Pozhidaev
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
Frontiers in Genetics
Frontiers in Genetics
GSK3B, BDNF, NGF, NRG1, HTR2C, and PIP4K2A play important roles in molecular mechanisms of psychiatric disorders. GSK3B occupies a central position in these molecular mechanisms and is also modulated by psychotropic drugs. BDNF regulates a number of
Autor:
G. G. Simutkin, Innokentiy S. Losenkov, Bob Wilffert, Anton J. M. Loonen, N. Vyalova, Anastasia Levchenko, Svetlana A. Ivanova, Nikolay A. Bokhan
Publikováno v:
Pharmacogenomics and Personalized Medicine. 11:121-126
GSK3B and AKT1 genes have been implicated in the pathogenesis of a number of psychiatric and neurological disorders. Furthermore, their genetic variants are associated with response to antidepressant pharmacotherapy. As the evidence is still incomple
Publikováno v:
European Neuropsychopharmacology. 40:S98-S99
Publikováno v:
European Neuropsychopharmacology. 29:S230-S231
Autor:
Diana Z Osmanova, L. A. Levchuk, N. Vyalova, Innokentiy S. Losenkov, Nikolay A. Bokhan, Taichi Ochi, Fokko J. Bosker, Ekaterina V Mikhalitskaya, S. Ivanova, Bob Wilffert, G. G. Simutkin, Antonius Loonen
Publikováno v:
European Neuropsychopharmacology, 29(Suppl. 6), S355-S356. ELSEVIER SCIENCE BV
Autor:
Arkadiy V. Semke, Diana Z Osmanova, Bob Wilffert, Maxim B. Freidin, Olga Yu Fedorenko, Svetlana A. Ivanova, Vladimir V Tiguntsev, Elena G Kornetova, Anton J. M. Loonen, Nikolay A. Bokhan, Ivan V Pozhidaev, N. Vyalova, Anastasiia S Boiko
Publikováno v:
BMC MEDICAL GENETICS, 20(Suppl 1). BMC
BMC Medical Genetics
BMC Medical Genetics, Vol 20, Iss S1, Pp 35-44 (2019)
Osmanova, D Z, Freidin, M B, Fedorenko, O Y, Pozhidaev, I V, Boiko, A S, Vyalova, N M, Tiguntsev, V V, Kornetova, E G, Loonen, A J M, Semke, A V, Wilffert, B, Bokhan, N A & Ivanova, S A 2019, ' A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia ', BMC Medical Genetics, vol. 20, no. Suppl 1, 47, pp. 47 . https://doi.org/10.1186/s12881-019-0773-3
BMC Medical Genetics
BMC Medical Genetics, Vol 20, Iss S1, Pp 35-44 (2019)
Osmanova, D Z, Freidin, M B, Fedorenko, O Y, Pozhidaev, I V, Boiko, A S, Vyalova, N M, Tiguntsev, V V, Kornetova, E G, Loonen, A J M, Semke, A V, Wilffert, B, Bokhan, N A & Ivanova, S A 2019, ' A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia ', BMC Medical Genetics, vol. 20, no. Suppl 1, 47, pp. 47 . https://doi.org/10.1186/s12881-019-0773-3
Background Hyperprolactinemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 receptors (DRD2s) on the membranes of lactotroph cells within the pituitary gland. Certain antipsychotic drugs, e.g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312d15b8c005117315447c1cd150e5ea
https://research.rug.nl/en/publications/8a85f849-878c-4d09-884f-0e0db44f1093
https://research.rug.nl/en/publications/8a85f849-878c-4d09-884f-0e0db44f1093
Autor:
Anton J. M. Loonen, N. Vyalova, Diana Z Osmanova, A. Semke, Bob Wilffert, Svetlana A. Ivanova, Olga Yu Fedorenko, Ivan V Pozhidaev
Publikováno v:
European Neuropsychopharmacology, 29(Suppl. 1), S410-S411. ELSEVIER SCIENCE BV
Background: Schizophrenia is a severe mental disorder, usually treated with long-term anti-dopaminergic therapy. Although several theories have been lanced, pathophysiology of schizophrenia has not yet been elucidated. Identifying genetic factors con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a3e7848c1a3919425930eb8ceb6690
https://research.rug.nl/en/publications/4d85c316-243c-40de-b0cd-1ef6c5315a6d
https://research.rug.nl/en/publications/4d85c316-243c-40de-b0cd-1ef6c5315a6d
Publikováno v:
European Neuropsychopharmacology. 29:S331-S332
Autor:
Anton J. M. Loonen, Nikolay A. Bokhan, Lisanne M Geers, Bob Wilffert, Evgeniy V. Rudikov, N. Vyalova, A. F. Y. Al Hadithy, Petros Pechlivanoglou, Svetlana A. Ivanova, Jacobus R. B. J. Brouwers, Arkadiy V. Semke, Olga Yu Fedorenko
Publikováno v:
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 50, 172-177. PERGAMON-ELSEVIER SCIENCE LTD
Background: Tardive dyskinesia (TD) is a potentially irreversible consequence of long term treatment with antipsychotic drugs which is according to a well-known theory believed to be related to oxidative stress induced neurotoxicity. Dehydroepiandros